Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Several bright spots and lower losses

DNB's profits for the second quarter of 2020 were NOK 5 019 million, a decrease of NOK 1 115 million from the second quarter of 2019. The result is nonetheless significantly better than that of this year's first quarter, and the economic outlook is now less uncertain. After a very demanding start to the year, we are again seeing some bright spots for the Norwegian economy. The level of activity is higher, and this has affected DNB's results for the second quarter. “The situation is still challenging for many, not least for people who have been temporarily laid off and for businesses

Interim report January – June 2020

JANUARY – JUNE 2020 · Income MSEK 923 (656) · Profit after tax, MSEK 908 (470) · Profit after tax per share, SEK 5.07 (2.80) APRIL – JUNE 2020 · Income MSEK 493 (333) · Profit after tax, MSEK 249 (309) · Profit after tax per share, SEK 1.35 (1.84) SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER · Acquisition of a property portfolio for a value of SEK 4.9 billion in June, 79 percent of the rental income from which is tax funded, and divestment of a project property in Gothenburg at a value of MSEK 400. · Divestment of a retail property in central Linköping

Alfa Laval announces a recommended public cash tender offer for all shares in Neles

Alfa Laval AB (publ) ("Alfa Laval" or the "Offeror"), a Swedish public limited liability company, and Neles Corporation ("Neles" or the "Company") have on 13 July 2020 entered into a combination agreement (the "Combination Agreement") pursuant to which Alfa Laval will make a voluntary recommended public cash tender offer for all issued and outstanding shares in Neles that are not held by Neles or any of its subsidiaries (the "Tender Offer"). In the Tender Offer, Neles’ shareholders will be offered a cash consideration of EUR 11.50 for each issued and outstanding share in Neles (the "Offer

Multiconsult nominated for significant contract on the new hospital at Gaustad (nye Rikshospitalet)

Helse Sør-Øst RHF has nominated Multiconsult for the design contract (phase 1) for the new hospital at Gaustad (nye Rikshospitalet) in Oslo. The contract involves the pre-design and includes all disciplines in the line of work, including an option for the detailed planning and construction phase.Multiconsult's fully owned subsidiary LINK arkitektur, as well as Fabel Arkitekter, Bølgeblikk arkitekter and Erichsen & Horgen AS are subcontractors. The new hospital at Gaustad (nye Rikshospitalet) will consist of approximately 140.000m2. The hospital will include regional and national

Half-year Report 2020

JANUARY 1 – JUNE 30, 2020(compared with the corresponding period a year ago) · Net sales declined 1.0% to SEK 62,119m (62,724) · Organic net sales declined 0.9% · Essity has increased market shares in many markets and increased online sales · Sales were negatively impacted by the COVID-19 pandemic and related lockdowns · In emerging markets, which accounted for 36% of net sales, organic net sales increased 2.3% · Operating profit before amortization of acquisition-related intangible assets (EBITA) increased 43% to SEK 9,159m (6,412) · Adjusted EBITA increased 32% to

Volati’s results better than expected

Volati announces that the Group’s results for Q2 2020 are better than it believes the market is expecting. According to preliminary figures for Q2, the Group’s net sales increased by 6 percent to SEK 1,889 (1,776) million and EBITA increased by 41 percent to SEK 181 (129) million compared with the same quarter the previous year. For the first six months, EBITA increased by 46 percent to SEK 243 (166) million compared with the same period the previous year.  “Volati has continued to develop positively in the second quarter with very strong earnings growth. Since the IPO in 2016, we have

Orkla ASA: Strong growth for Orkla’s brands

Orkla’s operating profit (EBIT adj.) increased by 8.7% to NOK 1,205 million in the second quarter of 2020. Operating revenues rose by 5.3% to NOK 11,099 million. Adjusted earnings per share increased in the quarter by 18% to NOK 1.10.Orkla’s Branded Consumer Goods operations, including Headquarters, had a 16% improvement in operating profit. The improvement is a result of factors including cost-cutting measures related to the coronavirus pandemic, productivity improvements and positive currency translation effects. Four out of five business areas had a marked improvement in operating

Instalco expands its heating & plumbing operations in Finland

Instalco has acquired Uudenmaan Lämpötekniikka Oy (ULT) in Helsinki, thereby expanding its heating & plumbing operations in Finland.The company has 46 employees and its sales for the 2018/2019 financial year were approximately SEK 75 million. This acquisition brings the total to 12 subsidiaries owned by Instalco in Finland, of which 6 offer heating & plumbing installations and 6 work with electrical installations. “ULT is a specialist company that fits nicely with the Instalco model and is a good match with our other subsidiaries in Finland. We expect that there will be many

Lantmännen’s harvest forecast: A normal harvest for 2020

Lantmännen forecasts that the annual harvest will amount to 6.1 million tons in total. The coronavirus pandemic has clearly shown how important Swedish agriculture and a functioning food chain are for Sweden’s ability to be self-sufficient, and the Swedish harvest is the basis for this.Lantmännen’s forecast for the annual harvest of grain, oilseed crops and pulses amounts to 6.1 million tons, which is lower than last year’s bumper harvest but slightly above the five-year average. “We are expecting a good harvest in Sweden this year, in terms of both volume and quality, although there

Read original

Early publication of Essity’s Half-year Report 2020

Essity’s Half-year Report for 2020 will be published on Monday, July 13 at approximately 7:00 a.m. CET instead of Friday, July 17 as previously communicated. The reason for the earlier publishing date is the uncertainty entailed by the ongoing COVID-19 pandemic. In conjunction with publication, a telephone and web presentation will be held on July 13 at 9:00 a.m. CET where President and CEO Magnus Groth will present the report and answer questions.Presentation:Date: Monday, July 13, 2020Time: 9:00 a.m. CETLink to web presentation: https://essity.videosync.fi/2020-07-13Telephone: +44

Scandion Oncology announces that the results of the 4 SCO-101 clinical phase I trials have been published in the journal “Basic & Clinical Pharmacology & Toxocology”.

Scandion Oncology A/S (“Scandion Oncology”) announces that the results from the 4 SCO-101 phase I clinical trials have been published in the International peer-reviewed journal” Basic & Clinical Pharmacology & Toxicology”.“An important part of drug development is to publish the results from the different development phases in order to allow a more detailed evaluation of the development. I am very happy that we can now present the data from the 4 clinical phase I studies that were performed by the former owner of SCO-101. As previously announced, SCO-101

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 21 330 treasury shares on 10 July 2020. The shares were purchased at an average price of price of NOK 54.0933. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 484 745 treasury shares.   Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no  Selvaag Bolig ASA is a residential property developer which controls the entire value chain from acquisition of land to sale of turnkey homes. The company has several thousand

Bambuser continues US growth – enters into agreement with fashion discovery platform Moda Operandi

Bambuser AB continues to grow in the US market with yet another new multi-brand retailer in the luxury segment. Today, Bambuser has entered into an agreement with Moda Operandi, one of the world's leading platforms for fashion discovery.   Moda Operandi (modaoperandi.com) is one of the world's leading platforms for designer fashion discovery. With an innovative mix of commerce and content, Moda Operandi offers more than 1,000 luxury brands and designers across fashion, fine jewelry and home, and ships to 125 countries. Bambuser has today signed a new agreement with Moda

Primary insider disclosure

The following primary insiders (or their related parties as described below) have, as part of the company's incentive program, committed to acquire shares in Ocean Yield ASA (the "Company" or "Ocean Yield"): · Lars Solbakken, CEO of Ocean Yield ASA, has through his wholly owned company Finmarine AS acquired 50,000 shares in Ocean Yield. Upon completion of such acquisition, Lars Solbakken will own, directly or indirectly, 1,640,880 shares in the Company. ·  Marius Magelie, SVP Finance & Investor Relations, has through his wholly owned company MGM Invest AS committed to acquire 7,500

Simris rights issue was oversubscribed

Simris (FNSE: SIMRIS) has concluded its rights issue of units which was announced on 12 June 2020. The subscription rate was circa 101.6 percent in total, of which circa 61.2 percent was subscribed with unit rights and circa 40.4 percent without unit rights. Consequently, underwriting commitments will not be called on. Simris receives circa SEK 29.1 million before transaction costs from the rights issue, of which circa SEK 2.2 million will be funded through offset of debt.IMPORTANT INFORMATION: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO AUSTRALA, HONGKONG,

BioStock: Aptahem comments on the new Covid-19 project

Last night, Malmö-based Aptahem announced that they have entered a preclinical collaboration with the University Health Network in Toronto. The collaboration will be anchored in Aptahem’s previously indicative positive preclinical data, and the objective is to evaluate whether the company’s drug candidate Apta-1 can show a positive treatment effect on the Acute Respiratory Distress Syndrome that can affect severe cases of Covid-19. BioStock contacted Aptahem’s CSO Dr Luiza Jedlina for a comment.Read the full interview at biostock.se: https://www.biostock.se/en/aptahem-comments-on-the-new-

Flowscape wins new orders in Australia

One of Flowscapes global customers is expanding their installations in Australia with a new office in Brisbane and a complementing order for their Sydney office. The Flowscape solution will be an important part for a safe return to the offices after the Covid-19 lock down. The order value is 1.3 MSEK first year and thereafter SEK 300,000 annually."Over the past month, we have seen a great interest from several countries for our new Covid-19 solution for safe social distancing at the office. With this order, our system will be used in two large offices in Australia with a total of over 1000

Vator Securities: CREATE Health delivers another exciting tech, ProMIS, which potentially could open up a world of new IP for Immunovia

In our latest research update on Immunovia (link to report ), we presented our forecast of a future diagnostic regimen including a combination of proteomics and genomics-based techs to generate timely and correct diagnosis of cancer. Published in the impactful Nature Communication Biology, (link to article ), Immunovia’s research arm and collaborator CREATE Health demonstrates the powerful combination of the two techs in its novel academic research project, the ProMIS platform. The

Storytel acquires the Nordic audiobook production company Earselect

Storytel AB (publ) (“Storytel”), Northern Europe’s leading audiobook and e-book streaming service, is acquiring an 80 percent majority interest in Earselect AB, a Nordic production company offering a dynamic, flexible and scalable cloud based platform specialised in remote audiobook production.With Storytel AB as new majority owner, Earselect’s efficient technology for both traditional production and a remote workflow, will support Storytel’s production line, and also continue to provide high quality and cost-efficient productions to external publishers with full business integrity as

AGENT study update with regards to COVID-19

GOTHENBURG, Sweden, July 10, 2020 – Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL), informs that the outbreak of COVID-19 has affected the general situation of the AGENT study activities. Patient recruitment has been ongoing without interruption during the pandemic, but the effects of COVID-19 may result in a delay of the full enrolment by up to three months.As hospitals, regions and countries have updated their guidelines, Isofol has adapted accordingly to be fully compliant with the new procedures. In order to ensure continuity of the ongoing AGENT study in a

Sold Out Signs Two New Titles

Today, EG7 announces that the subsidiary Sold Out has signed publishing agreements regarding two new titles. The signed publisher agreements concern developer ColePowered Games' upcoming sci-fi title Shadows of Doubt as well as an as a yet unannounced title from Auroch Digital. The two titles join Sold Out's fast-growing portfolio of digital titles. More information will be communicated in the coming months. Comment from Robin Flodin, CEO of EG7: “We are pleased that Sold Out has signed agreements with both ColePowered Games and Auroch Digital, two very talented developers that

There are no items matching the current filter
There are no more items matching the current filter
Back to top